An Observational Study to Collect Information on the Safety of Gadolinium-Based Contrast Agents in Patients in India

Conditions: Contrast Enhancement in Magnetic Resonance Imaging Interventions: Drug: GBCAs Sponsors: Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials